Skip to main content

Advertisement

Log in

Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions

Biopsia mammaria in stereotassi, vacuum-assisted, in 268 lesioni non palpabili

  • Breast Radiology Senologia
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

We evaluated the reliability of stereotactic vacuum-assisted breast biopsies (VAB) from our personal experience.

Materials and methods

Between January 2003 and December 2005, 268 patients underwent VAB with an 11-gauge probe at our institution. Inclusion criteria were nonpalpable lesions, undetectable by ultrasound and suspected at mammography (microcalcifications, circumscribed mass, architectural distortion), for which cytology and/or core biopsy could not provide a definite diagnosis. Lesion mammographic patterns were microcalcifications in 186 cases (77.5%), mostly localised clusters (130/186: 70%); circumscribed mass with or without microcalcifications in 36 cases (15%) and architectural distortion with or without microcalcifications in 18 cases (7.5%). On the basis of the Breast Imaging Reporting and Data System (BI-RADS) classification, 16 cases (7%) were graded as highly suspicious for malignancy (BI-RADS 5), 81 (34%) as suspicious for malignancy (BI-RADS 4b), 97 (40%) as indeterminate (BI-RADS 4a) and 46 (19%) as probably benign (BI-RADS 3). Lesion size was ≤10 mm in 161 cases (67%) and > 20 mm in only 38 cases (16%), 30 of which appeared as microcalcifications.

Results

In 28/268 lesions (10.5%) the biopsy could not be performed (nonidentification of the lesion; inaccessibility due to location or breast size). In 12/240 (5%) biopsies, the sample was not representative. Pathology releaved 100/240 (42%) malignant or borderline lesions and 140/240 (58%) benign lesions. Among the malignant lesions, 16/100 (16%) were invasive carcinoma [infiltrating ductal carcinoma (IDC) or infiltrating lobular carcinoma (ILC)], 13/100 (13%) were microinvasive (T1mic), 35/100 (35%) were ductal carcinoma in situ (DCIS), 9/100 (9%) were lobular carcinoma in situ (CLIS). Among the borderline lesions, 27/100 (27%) were atypical epithelial hyperplasia [atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH)]. In 9/100 surgically treated lesions (9%), there was discordance between the microhistological findings of VAB and the pathological results of the surgical procedure: 8/9 were underestimated by VAB (four ADH vs. DCIS, three DCIS vs. IDC, one ADH vs. IDC), and 1/9 was overestimated (T1mic vs. DCIS). Complications following VAB occurred in 9/240 patients (3.7%).

Conclusions

In our experience, VAB showed fair reliability in the diagnosis of nonpalpable breast lesions despite a portion of failed (10.5%), nonsignificant (5%) procedures and underestimated lesions (9%).

Riassunto

Obiettivo

Valutare l’accuratezza del sistema di agobiopsia mammaria in stereotassi con metodica multidirezionale e dispositivo aspirante sotto vuoto (VAB) nell’esperienza personale, al fine di dimostrare la validità di questa metodica.

Materiali e metodi

Nel periodo compreso fra gennaio 2003 e dicembre 2005, 268 pazienti sono state sottoposte a manovra ago-bioptica con VAB utilizzando ago 11-gauge. Sono state avviate al VAB tutte le pazienti con alterazioni sospette alla mammografia, non riconoscibili con ecografia, non palpabili (focolai di microcalcificazioni, minuscole lesioni focali con o senza microcalcificazioni, aspetti di sovvertimento) in cui la tipizzazione non poteva essere ottenuta con metodiche alternative (citologia e/o core-biopsy) e non si riteneva opportuno il follow-up. L’aspetto radiologico delle lesioni è stato di microcalcificazioni in 186 casi (77,5%), per lo più distribuite in unico focolaio (130/186: 70%); opacità focale con o senza microcalcificazioni in 36 casi (15%), infine, in 18 casi (7,5%) distorsione, con o senza microcalcificazioni. Utilizzando la classificazione BIRADS il giudizio radiologico è stato “altamente sospetto” di malignità (BIRADS 5) in 16 casi (7%), “sospetto” di malignità (BI-RADS 4b) in 81 casi (34%), “indeterminato” (BI-RADS 4a) in 97 casi (40%) e “probabilmente benigno” (BI-RADS 3) in 46 casi (19%). Centosessantuno lesioni (67%) avevano diametro ≤10 mm; solo 38 lesioni (16%) erano >20 mm,la maggior parte di queste, 30 casi, si manifestavano alla mammografia sotto forma di microcalcificazioni.

Risultati

In 28/268 casi (10,5%) non è stato possibile procedure al prelievo (mancata visualizzazione della lesione, inaccessibilità al bersaglio per sede della lesione o ridotto spessore della mammella). Il campione è risultato non significativo in 12/240 procedure espletate (5%). Il riscontro di patologia francamente maligna o di lesioni border-line si è verificato nel 42% dei casi (100/240), nei restanti 140 casi (58%) si è rilevata patologia benigna. Fra le lesioni maligne, è stata posta diagnosi di carcinoma infiltrante (CDI e CLI) in 16 casi (16/100: 16%), di carcinoma microinfiltrante (T1mic) in 13 casi (13/100: 13%), di carcinoma duttale in situ (CDIS) in 35 casi (35/100: 35%); di carcinoma lobulare in situ (CLIS) in 9 casi (9/100: 9%) e di iperplasia epiteliale atipica (ADH e ALH) in 27 casi (27/100:27%). In 9/100 lesioni (9%) si è avuta discordanza fra i reperti microistologici del VAB e i risultati patologici delle procedure chirurgiche: 8/9 sono state sottostimate dal VAB (4 ADH vs CDIS, 3 CDIS vs CDI, 1 ADH vs CDI) e 1/9 è stata sovrastimata (T1mic vs CDIS). La comparsa di complicanze in seguito a manovra bioptica con VAB si è verificata in 9/240 pazienti (3,7%).

Conclusioni

Il prelievo con VAB è risultato essere nella esperienza personale metodica discretamente affidabile nella tipizzazione di lesioni mammarie non palpabili, seppur gravata da una quota di procedure mancate (10,5%), di campionamenti non significativi (5%), ed infine da lesioni sottostimate (9%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References/Bibliografia

  1. Ciatto S, Cataliotti L, Distante V (1987) Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology 165:99–102

    PubMed  CAS  Google Scholar 

  2. Meyer JE, Kopans DB, Stomper PC et al (1984) Occult breast abnormalities: percutaneous preoperative needle localization. Radiology 150:335–337

    PubMed  CAS  Google Scholar 

  3. Kopans DB (1992) The positive predictive value of mammography. AJR Am J Roentgenol 158:521–526

    PubMed  CAS  Google Scholar 

  4. Ciatto S, Rosselli Del Turco M, Ambrogetti D et al (1997) Solid nonpalpable breast lesions. Success and failure of guided fine-needle aspiration cytology in a consecutive series of 2444 cases. Acta Radiol 38:815–820

    Article  PubMed  CAS  Google Scholar 

  5. Leifland K, Lagerstedt U, Svane G (2003) Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 nonpalpable breast lesions. Acta Radiol 44:387–391

    Article  PubMed  CAS  Google Scholar 

  6. Parker SH, Burbank F, Jackman RJ et al (1994) Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 193:359–364

    PubMed  CAS  Google Scholar 

  7. Liberman L, Dershaw DD, Glassman JR et al (1997) Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 203:151–157

    PubMed  CAS  Google Scholar 

  8. Liberman L, Sama MP (2000) Costeffectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 175:53–58

    PubMed  CAS  Google Scholar 

  9. Burbank F (1997) Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 202:843–847

    PubMed  CAS  Google Scholar 

  10. Dhillon MS, Bradley SA, England DW (2006) Mammotome biopsy: impact on preoperative diagnosis rate. Clin Radiol 61:276–281

    Article  PubMed  CAS  Google Scholar 

  11. Kettritz U, Morack G, Decker T (2004) Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: radiological and pathological correlations. Eur J Radiol 55:270–276

    Article  PubMed  Google Scholar 

  12. Orel SG, Kay N, Reynolds C et al (1999) BI-RADS categorization as a predictor of malignancy. Radiology 211:845–850

    PubMed  CAS  Google Scholar 

  13. Parker SH, Klaus AJ (1997) Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics 17:1233–1252

    PubMed  CAS  Google Scholar 

  14. Heywang-Kobrunner SH, Schaumloffel U, Viehweg P et al (1998) Minimally invasive stereotaxic vacuum core breast biopsy. Eur Radiol 8:377–385

    Article  PubMed  CAS  Google Scholar 

  15. Della Sala SW, Pellegrini M, Bernardi D et al (2004) Advantages and limits of percutaneous breast core biopsy with Mammotome and stereotactic equipment in upright seated patient. Radiol Med 108:335–344

    PubMed  Google Scholar 

  16. Cangiarella J, Waisman J, Symmans WF et al (2001) Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup. Cancer 91:173–177

    Article  PubMed  CAS  Google Scholar 

  17. Jackman RJ, Nowels KW, Rodriguez-Soto J, et al (1999) Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 210:799–805

    PubMed  CAS  Google Scholar 

  18. Philpotts LE, Shaheen NA, Carter D et al (1999) Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol 172:683–687

    PubMed  CAS  Google Scholar 

  19. Kettritz U, Rotter K, Schreer I et al (2004) Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer 100:245–251

    Article  PubMed  Google Scholar 

  20. Giardina C, Guerrieri AM, Ingravallo G et al (2002) The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination. Pathologica 94:182–189

    Article  PubMed  CAS  Google Scholar 

  21. Philpotts LE, Lee CH, Horvath LJ et al (1997) Canceled stereotactic core-needle biopsy of the breast: analysis of 89 cases. Radiology 205:423–428

    PubMed  CAS  Google Scholar 

  22. Liberman L, Smolkin JH, Dershaw DD et al (1998) Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 208:251–260

    PubMed  CAS  Google Scholar 

  23. Ciatto S, Houssami N, Ambrogetti D et al (2006) Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat 2006 101:291–297

    Article  Google Scholar 

  24. Brenner RJ, Fajardo L, Fisher PR et al (1996) Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol 166:341–346

    PubMed  CAS  Google Scholar 

  25. Meyer JE, Smith DN, DiPiro PJ et al (1997) Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device. Radiology 204:575–576

    PubMed  CAS  Google Scholar 

  26. Apesteguia L, Mellado M, Saenz J et al (2002) Vacuum-assisted breast biopsy on digital stereotaxic table of nonpalpable lesions non-recognisable by ultrasonography. Eur Radiol 12:638–645

    PubMed  CAS  Google Scholar 

  27. Won B, Reynolds HE, Lazaridis CL et al (1999) Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR Am J Roentgenol 173:227–229

    PubMed  CAS  Google Scholar 

  28. Jackman RJ, Birdwell RL, Ikeda DM (2002) Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 224:548–554

    Article  PubMed  Google Scholar 

  29. Brenner RJ, Bassett LW, Fajardo LL et al (2001) Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology 218:866–872

    PubMed  CAS  Google Scholar 

  30. Liberman L, Abramson AF, Squires FB et al (1998) The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol 171:35–40

    PubMed  CAS  Google Scholar 

  31. Meyer JE, Smith DN, Lester SC et al (1999) Large-core needle biopsy of nonpalpable breast lesions. JAMA 281:1638–1641

    Article  PubMed  CAS  Google Scholar 

  32. Darling ML, Smith DN, Lester SC et al (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 175:1341–1346

    PubMed  CAS  Google Scholar 

  33. Brem RF, Behrndt VS, Sanow L et al (1999) Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 172:1405–1407

    PubMed  CAS  Google Scholar 

  34. Jackman RJ, Burbank F, Parker SH et al (2001) Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497–450

    PubMed  CAS  Google Scholar 

  35. Jackman RJ, Rodriguez-Soto J (2006) Breast microcalcifications: retrieval failure at prone stereotactic core and vacuum breast biopsy-frequency, causes, and outcome. Radiology 239:61–70

    Article  PubMed  Google Scholar 

  36. Burbank F (1997) Stereotactic breast biopsy: comparison of 14-and 11-gauge Mammotome probe performance and complication rates. Am Surg 63:988–995

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Girardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonegutti, M., Girardi, V. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions. Radiol med 113, 65–75 (2008). https://doi.org/10.1007/s11547-008-0226-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-008-0226-0

Keywords

Parole chiave

Navigation